Description
Benlysta (belimumab) is a prescription medication from GlaxoSmithKline LLC, administered as a subcutaneous injection to inhibit B lymphocyte activation, helping manage autoimmune conditions like lupus. It comes in 200 mg/mL strength in prefilled syringes. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Belimumab | HTML | Access the FDA dataset for Belimumab — ANDA 125370 submitted by Mylan Institutional LLC | Open resource |